Notes / Company

Krebs Biochemicals & Industries Ltd.

KREBSBIO BSE 524518 ISIN INE268B01013 Pharmaceuticals

Fundamentals

Market cap: ₹126 cr
P/E: -7.50×
ROE: 18.48%
Debt / equity: -1.45
52-week range: 38.33 — 113.50

Research on Tijori Finance

The timeline — 1 note on Krebs Biochemicals & Industries Ltd.

May 2026

21 May 26 · 13:24 IST Brief

Brief · Earnings

Krebs Biochemicals revenue halved as Vizag plant stays shut

FY26 revenue fell to ₹2,373.16 lacs from ₹4,331.19 lacs; net loss narrowed to ₹1,693.31 lacs but net worth deepened to negative ₹16,275.47 lacs. Plant remains closed since Feb 2025.

Verify on exchange BSE filings for KREBSBIO NSE filings for KREBSBIO Tijori Finance company page